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osting by EAbstract Staphylococcus aureus is one of the major causes of community and hospital-acquired
infections. Bacteriophage considered as a major risk factor acquires S. aureus new virulence genetic
elements. A total number of 119 S. aureus isolated from different specimens obtained from (RKH)
were distinguished by susceptibility to 19 antimicrobial agents, phage typing, and PCR ampliﬁca-
tion for mecA gene. All of MRSA isolates harbored mecA gene, except three unique isolates. The
predominant phage group is belonging to the (mixed group). Phage group (II) considered as an epi-
demiological marker correlated to b-lactamase hyper producer isolates. MRSA isolates indicated
high prevalence of phage group (II) with highly increase for phage types (Ø3A), which were corre-
lated to the skin. Phage types (Ø80/Ø81) played an important roll in Community Acquired Meth-
icillin Resistant S. aureus (CAMRSA). Three outpatients MRSA isolates had low multiresistance
against Bacitracin (Ba) and Fusidic acid (FD), considered as CAMRSA isolates. It was detected
that group I typed all FD-resistant MSSA isolates. Phage groups (M) and (II) were found almost
to be integrated for Gentamycin (GN) resistance especially phage type (Ø95) which relatively
increased up to 20% in MRSA. Tetracycline (TE) resistant isolates typed by groups (II) and
(III) in MSSA. Only one isolate resistant to Sulphamethoxazole/Trimethoprim (SXT) was typed
by (III/V) alone in MSSA. MRSA isolates resistant to Chloramphenicol (C) and Ba were typed
by all groups except (V). It could be concluded that (PERSA) S. aureus isolates from the wound
that originated and colonized, and started to build up multi-resistance against the topical treatment. Al-Khulaiﬁ Manal).
ity. All rights reserved. Peer-
d University.
lsevier
38 M. Al-Khulaiﬁ Manal et al.antibiotics. In this study, some unique sporadic isolates for both MRSA and MSSA could be used
as biological, molecular and epidemiological markers such as prospective tools.
ª 2009 King Saud University. All rights reserved.1. Introduction
Staphylococcus aureus is a versatile important human pathogen
causing a number of variety medical infections. In the other
wise, the fact that 90% of hospital staff are carriers of S. aureus
portends serious for the epidemiology and pathogenesis of
Staphylococcal infections (Fey et al., 2003; Lacey et al.,
1984). The wide spread of antibiotic resistance among
S. aureus strains is a major concern in the treatment of Staph-
ylococcus infections. These strains often resistance to multiple
antibiotics with attendant increased morbidity; the surveillance
and control of these strains was highly desirable (Mathur and
Mehudiratt, 2000; Lyon and SKurray, 1987). The increasing
importance of MRSA as a cause of nosocomial infections can
be inferred from several recent studies (Schmitz et al., 1997).
There is relatively little information on the diversity of strains
causing infection. It is important to have knowledge of the most
common strains associated with human infections and their
sources in each episodes and environment in order to improve
our understanding of the epidemiology of this pathogen and
solve the problems. Although bacterial interaction is a well rec-
ognized phenomenon, there has been surprisingly little research
with respect to MRSA and MSSA. The mechanism/s responsi-
ble for this phenomenon is not readily apparent. Gopal Rao
andWong (2003) concluded that there is a complex relationship
between various strains of EMRSA andMSSA especially in the
skin. This interaction may have an important bearing on colo-
nization of patients with MRSA. It may explain some of the
epidemiological and clinical observations as well as under-
standing the methods for the movement of resistant genes, like:
Transduction (phages) – Plasmids – Integrons – Transposons.
In Saudi Arabia, signiﬁcant increase of MRSA was noticed
from 6.9% to 33% starting in the last decade from 1995 up to
2004 alarming it remarkably, as an outbreak of EMRSA and
EMSSA. Several investigations were done concerning the
screening and emergence of MRSA in the Kingdom. Belkum
et al. (1997) identiﬁed that MRSA Saudi isolates all belonging
to phage group III. It was clear that consensus SmaI pattern
observed for Saudi strains was different from other non-re-
lated isolates.
Kishan et al. (1998) reported for the most b-lactamase-pro-
ducing isolates of S. aureus belonging to other phage groups.
Skov et al. (1995) have reported that all phage group II isolates
recovered prior to harbored blaz on the chromosome. The ﬁnal
event in multiplication of phage was lysis of the host cell by
murein hydrolyses of various substrate speciﬁcities (Young,
1992; Loessner et al., 1995, 1998).
The genetic studies that showed that drug-resistance genes
were easily transduced among S. aureus cells by prophage
(Mitsuhashi et al., 1965). This suggested a relationship between
the intracellular state of the drug-resistance genes and temper-
ate phages. Thus, they could show that some of the temperate
phages transduced the drug-resistance genes.
The aim of this study is to approach questions related to the
spread of MRSA in Saudi cohort by examining phenotypic
(resistance to antibiotics, phage typing) and the existed geneticbackgrounds mecA gene. As well as deﬁned the epidemic drift
of phage-types within originated susceptible wild type S. aur-
eus population as a microbial biomarkers for monitoring the
usage of antibiotics. And analyze the contribution of the phage
typing, as a phenotypic marker and answer question such as:
are the phage types between isolates similarly or differently?
 What is the homogeneity and heterogeneity between MSSA
and MRSA?
 Which of S. aureus isolates carrying the mecA gene?
 What are the antimicrobial resistance determinants that
phage could contribute?2. Materials and methods
2.1. Bacterial isolates
A total numbers of 119 isolates of S. aureus from different pa-
tients were collected over a period of one year from 2003 to
2004 from microbiology laboratory in Riyadh Armed Forces
Hospital (RAFH). The following reference strains of bacterial
species were used as controls:
Methicillin resistant S. aureus (MRSA) (NCTC 10442),
methicillin sensitive S. aureus (MSSA) (ATCC 25923)
Coagulase Negative Staphylococcus epidermidis (CNS)
(ATCC 12228).
Identiﬁcation of S. aureus isolates
The suspected colonies were identiﬁed according to the fol-
lowing criteria:
2.2. Colonial morphology
All isolates were streaked for purity growth on Blood Agar
plates (Blood Agar Base.Oxoid.Code: CM55) for over night
incubated at 37 C (Collee et al., 1989).
2.3. Microscopic examination
Gram stain smears from a Staph Culture showed gram positive
cocci in clusters.
2.4. Catalase test
This test detects the presence of cytochrome oxidase enzymes
in Micrococcaceae according to Konerman et al. (1992).
2.5. Coagulase test
Slide agglutination test (Staphurex) based on the detection
of clumping factor and protein A. The test was performed
by Slidex Staph-kit (BioMereux, Chabonnieres-Bain
France) according to MacFaddin (1980) and Baron et al.
(1994).
Phage typing, PCR ampliﬁcation for mecA gene, and antibiotic resistance patterns 39Tube coagulase test measures the production of free coagu-
lase (Staphylocoagulase). The test (Remel Coagulase plasma.
Rabbit plasma w/EDTA) was performed according to Fair-
brother and Chapman (1940), Piper et al. (1988) and Luijen-
dijk et al. (1996).
2.6. Manitol fermentation
All isolates were streaked onto Manitol Salt Agar (MSA) (Ox-
oid.Code: CM85). If the manitol was fermented to produce
acid, the phenol red in then medium changes color from red
to yellow. If this color change exists, it can be presumed that
the isolate is a strain of S. aureus.
2.7. Deoxyribonuclease (DNase) test
This test was performed by heavily spot-inoculating several
colonies on nutrient agar media (Oxoid.Code: CM3) contain-
ing DNA. Colonies of S. aureus that produced DNase were
surrounding by a clear zone where the DNA had been depoly-
merized and hydrolyzed as done by Franki and Murray (1986)
and Duguid (1989).
2.8. Detection of methicillin resistance in S. aureus
Kirby–Bauer technique of disk diffusion method was used to
detect the methicillin resistance. The isolates were tested by
employing Mueller Hinton Agar (MHA) (Oxoid.Code:
CM337). The 1 lg oxacillin (OX) and cefoxitin (FOX) 30 lg
disk diffusion were used with MHA media supplemented with
4% NaCl was used to detect MRSA according to the NCCLS
National Committee for Clinical Laboratory Standards (2004).
Disk diffusion testing by FOX disk was performed to simulta-
neously evaluate its value in predicting OX resistance. Com-
mercial antimicrobial agents containing disks were placed on
the plates by multidispenser (Oxoid).
2.9. Genotypic method for identiﬁcation of S. aureus isolates and
detection of methicillin resistance
Triplex Polymerase Chain Reaction (PCR) method to amplify
three different genes was used according to Al-Shammary
(2005).
16SrRNA: a speciﬁc gene for Staphylococci species.
nuc: for detection of S. aureus.
mecA: to detect methicillin resistance strains.
2.10. DNA templet extraction
Two to four colonies overnight blood agar subculture of
S. aureus strains were taken and resuspended into 200 ml ofTable 1 Sequences of oligonucleotide primers for identiﬁcation of
Gene Primer Oligonucleotide sequence
mecA mecA1 50CTT TGC TAG AGT AG
mecA2 50GCT AGC CAT TCC TTT
16s RNA 16sf 50GTA GGT GGC AAG CG
16sr 50CGC ACA TCA GCG TC
nuc nuc1 50GCG ATT GAT GGT GA
nuc2 50AGC CAA GCC TTG ACPCR water (Molecular Biology Grade Water, eppendorf) in
an eppendorf tube, vortex and then centrifuged at 13,000
rpm for one min (just to form a pellet) then the DNA can be
obtained directly from the supernatant.
2.11. Primers
Oligonucleutide primers are listed in Table 1. The primers were
obtained from MWG-Biotech AG (Berlin, Germany).
2.12. PCR reaction mix
A total volume 25 ll of reaction mix was prepared by adding
1.5 ll of primer mix, the primer mix was done by adding 1 ll
from each mecA primers, 0.25 ll from each nuc primers and
from each 16srRNA primers. 4 mM MgCl2 (stock 25 mM),
12.5 ll Ready Mix (Ready Mix PCR, Master Mix Con.2X.
AB gene), {when Ready Mix used as 1· it will contain a con-
centration of 1.25U Thermo prime plus DNA polymerase,
75 mM tris HCl [ph:8.8], 20 mM (NH4)2SO4, 1.5 mM MgCl2,
0.01% (v/v) Tween 20, 0.2 mM dNTPs, precipitant and red
dye for electrophoresis} 2 ll PCR water and 5 ll Template
DNA. Each run contained the MRSA, MSSA and CNS stan-
dard strains with and two negative controls (blank reagent and
PCR water).
2.13. The cycling protocol
The reaction was carried by using the Thermal Cycler (TC)
from Gene Amp PCR system 9700 (Perkin–Elmer). The cy-
cling protocol consisted of one cycle for 5 min at 94 C, fol-
lowed by 30 cycles consisting of denaturation for 1 min at
94 C, annealing for 1 min at 55 C, and elongation for
2 min at 72 C then one cycle of ﬁnal elongation for 4 min at
72 C. After the ﬁnal cycle, the products were kept at 4 C till
the analysis done.
2.14. Products analysis
Ten microlitres of the product was loaded onto 2% Pulsed
Field Certiﬁed Agarose and electrophoresis was done at
120 V for 2 h (GT UVTP Gel tray 15 · 25 cm. GT-Gel cast-
ing system. Sub-Cell GT system Comb size 20 · 0.75 mm.
Power supply, Bio-Rad. Triss Borate EDTA (TBE), buf-
fer.10X. USB). After electrophoresis, the DNA visualized
by staining with ethidium bromide solution (Plus one. Phar-
macia Biotech. 1 lg/ml). The gel staining for 15–30 min.
Viewed under UV transillumination (Bio-Rad) and photo-
graph using gel documentation system, print image
(Bio-Rad P68V paper. 110 mm · 21 mm high density type)
and store it. Destain for 15–30 min in distilled water. TheS. aureus and detection of MRSA strains.
bp Quality control
C ACT CG 30 531 NCTC 10442
ATC TTG 30
T TAT CC 30 218 ATCC 12228
A G 30
T ACG GTT 30 280 ATCC 25923
G AACTAA AGC 30
40 M. Al-Khulaiﬁ Manal et al.DNA molecular size marker was used (100 Base-Pair ladder
1 lg/ll. Amersham Pharmacia Biotech Inc.). The analysis
of the DNA PCR products was evaluated according to
the following controls:
MRSA control NCTC 10442 (mecA, 16Sr RNA and nuc
positive)
MSSA control ATCC 25923 (mecA negative, 16SrRNA and
nuc positive)
CNS control ATCC 12228 (mecA and nuc negative, 16Sr
RNA positive)
PCR water (Negative control) (mecA, 16SrRNA and nuc
negative)
2.15. Isolates stored
S. aureus isolates were inoculated on blood agar plates and a
colonies from pure cultures were stored on nutrient agar slopes
at 4 C with subculture them every six months. In addition, the
isolates were also stored at 70 C in nutrient broth contained
15% glycerol. Several tubes of each culture were prepared and
only one were used for sub culturing each year. Before being
tested the isolates were removed from storage and streaked
onto blood agar plates and incubated under aerobic conditions
at 37 C for 18–24 h. All inoculate were prepared from these
subcultures (Miller, 1987).
2.16. Antibiotic susceptibility tests
The sensitivity methods were performed as described by Clin-
ical Microbiology procedures Handbook (Hindler, 1992). A
guide to sensitivity testing (Phillips et al., 1993) and Manual
of Clinical Microbiology (Woods and Washington, 1995).
Mueller Hinton plates (without salt) were inoculated in the
same way which was used for OX and FOX, by
Kirby–Bauer technique. The sensitivity was recorded
according to the NCCLS guidelines.
Modiﬁed stocks technique were performed by both the test
and control organisms were inoculated on the same plate. Sus-
ceptibility categories were interpreted according the stock’s
technique criteria. Reading the reaction of the test organism
to each antibiotic as ‘sensitive’ or ‘resistant’ as follows:
Sensitive (S): Zone radius wider than, equal to or not more
than 3mm smaller than the control. Resistant (R): No zone of
inhibition or zone radius measure 2 mm or less.
2.17. Phage typing
According to Laboratory of Hospital Infections, Central Pub-
lic Health Laboratory, Colindale. London which resembled
An International Human Staphylococcal Phage Typing Set
(IPS), containing 23 phages was used for discriminatory
isolates.
2.18. Propagation the phages
Suspend the dried phage in 1.0 ml of broth or we can use
1.0 ml of stock phages, and dilute in 10-fold steps to 1 in
1,000,000. Apply one 0.02 ml drop of each dilution to a dried
lawn of propagating strain and incubate overnight at 30 C,then we determine the titer and RTD. The RTD (routine test
dilution) is that dilution of phage which just fails to give con-
ﬂuent lysis (i.e. gives semi-conﬂuent lysis) on its propagating
strain. After that either soft agar or broth propagation meth-
ods might be used depend on the phage, as recommended in
the phage set but two methods were performed for all the
phages as follows:
2.19. Broth propagation
An overnight broth culture of the propagating strain at a dilu-
tion of 1/100 was added to nutrient broth containing calcium.
Phage suspension was added to give a ﬁnal dilution equivalent
of 1 · RTD/ml, if this does not give a satisfactory propagation
then input phage of 1/RTD and/or 10 · RTD/ml may also be
tried. The mixture was incubated at 37 C for 6 h, with shaking.
After incubation, the lysate was centrifuged, the supernatant
pipetted off and titrated (in some cases it may be desirable to
ﬁlter at this point). The titration plate was incubated overnight
at the temperature appropriate for the species; the supernatant
stored overnight at 4 C. If the titer is high enough – RTD
should be at least 1 in 10,000 the supernatant is ﬁltered through
a 0.45 ll ﬁlter, tested for sterility and re-titrated, Sterility test-
ing involves incubating aliquots of phage ﬁltrate in nutrient
broth for a week. The ﬁltrate is then distributed into screw-
capped bottles and stored at 4 Cwithout preservative. It is per-
missible to use chloroform to sterilize S. aureus phage 79.
2.20. Soft agar propagation
A slope culture of the propagating strain was prepared on
nutrient agar slope in a test tube. Fourteen centimetre Petri
dishes containing nutrient agar to a depth of approx 5 mm
were used. Prepared nutrient agar (soft agar) containing
0.5% agar which melted and cooled to 45 C. Calcium chlo-
ride (sterile) was added to give a ﬁnal calcium concentration
of 400 lg/ml. A suspension of the propagating strain, pre-
pared by suspending the growth from the nutrient agar
slope in 2 ml nutrient broth, is added to give a ﬁnal dilution
of 1/100. Add sufﬁcient phage to give near-conﬂuent lysis
after overnight incubation. This phage concentration varies
between phages, but was usually between 105 and
106 pfu/ml of soft agar. After mixing, 7.5 ml of the cell-
phage suspension was layered on the surface of each nutri-
ent agar plate. The plates are incubated, usually for 18 h at
the optimum temperature varies with phage. Most yield
higher titer propagation at 37 C. Broth was added per plate
and the soft agar layer scraped off with a sterile, bent glass
or plastic rod. Both broth and soft agar are taken off. The
agar lumps were broken up by rapid pipetting or shaking,
the mixture centrifuged and the supernatant was removed
and titrated.
2.21. Phage typing method
A two-hour, lightly inoculated, nutrient broth culture grown
with shaking at 37 C was used for typing. The grown culture
is used to ﬂood a plate containing appropriate agar, and the
excess culture removed. The ﬂooded plate is dried open and
this can take several hours, a minimum of 2 h is necessary.
Phage typing, PCR ampliﬁcation for mecA gene, and antibiotic resistance patterns 41Phages, appropriate for the species, are applied at 100· RTD
by using multi-head inoculators. Lids are replaced as soon as
the phages suspension has been applied. After drying, the
plates are incubated overnight at 30 C. Phage reaction were
read, by eye, and recorded on the conventional phage scales
according to Public Health Laboratory, Colindale, London.1 1–5 plaques
2 6–19 plaques
3 20–49 plaques
8 50 ors more plaques
9 Conﬂuent lysis
0 Inhibition reaction (inhibition, or thinning of bacterial
growth)
– No reaction3. Results
3.1. S. aureus isolates identiﬁcation
The colonized 119 isolates of S. aureus on BA plates showed
smooth, slightly domed colonies with 1–2 mm diameters. AllFigure 1 Ampliﬁcation of three genes: mecA for MRSA, nuc for S
primers for each. Lanes: 1–14 showed the PCR products of S. aureus st
Lane () is a negative control. Lanes: 3 and 8 harbored mecA gene, whi
exhibit positive controls. M: is a 1000 bp DNA marker.
Table 2 Antibiotic susceptibility tests for 77 MSSA isolates againsisolates were positive to catalase, Staphurex, manitol fermenta-
tion, tube coagulase and DNase tests. All isolates were contain
the 16sRNA and nuc genes which identiﬁed as S. aureus by
genotypic method in Fig. 1.3.2. Detection of methicillin resistance in S. aureus
OX and FOX disks diffusion methods were applied for detec-
tion of MRSA according to NCCLS, that recommended the
use of the cefoxitin disk test as a surrogate marker for the
detection of oxacillin resistance in Staphylococcal isolates.
Seventy-seven isolates were identiﬁed as MSSA strains and
42 isolates were characterized as MRSA strains. The results
were conﬁrmed by PCR detection for mecA gene. Thirty-nine
out of 42 MRSA isolates were positive for mecA gene in Fig. 1.
3.3. Antimicrobial susceptibility patterns of S. aureus
Antibiotics susceptibility among S. aureus isolates is summa-
rized in Tables 2 and 3, Figs. 2–4.
The 77 MSSA isolates were classiﬁed into 14 various anti-
biograms from (a) to (n). 42 MRSA isolates were classiﬁed into. aureus and 16SrRNA for Staphylococci genus using the speciﬁc
udied DNA samples compared to the mentioned positive controls.
le the others proved to be MSSA lacking mecA. The last three lanes
t 19 antibiotics.
Table 3 Antibiotic susceptibility tests for 42 MRSA isolates against 19 antibiotics.
R: Resistant to, S: Sensitive to, PG 10: Penicillin, OX: Oxacillin, FOX: Cefoxitin, CXM: Cefuroxime, AMC: Augmantin, SXT: Sulpha-
methoxazole/Trimethoprim, C: Chloramphenicol, VA: Vancomyc, TEC: Ttechoplanin, GN: Gentamycin, AK: Amikacin, MUP 5: Mupirocin
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Figure 3 Prevalence of multi r
42 M. Al-Khulaiﬁ Manal et al.19 antimicrobial agents were (from A to U) in Table 3 and
Fig. 3.
For b-lactam antibiotic+b-lactamase inhibitor (AMC), all
MSSA isolates demonstrated susceptible to it. While 88% of
MRSA isolates were resistant. For other antibiotics, the resis-
tance rates were signiﬁcantly increased in MRSA isolates com-
pared with the MSSA. In contrast, the resistance to Ba
antibiotic in MSSA (Table 2) was higher than that was found
in MRSA which was 32.4% in the former and 19% in the lat-
ter in Table 3. So, all isolates (both MSSA and MRSA) dem-
onstrated susceptibility to glycopeptides (VA and TEC)
(Fig. 4).
It was observed a group of 29 isolates emerged out of 77 of
MSSA had resistant for two or three of the antibiotics, which
occurred in Table 2.J K L N O Q R T U I
ntibiograms
Mup5 Mup200 B E Te RD FD Cip




















































































































Figure 5 Phage typing patterns of MRSA isolates.
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3.4.1. Distribution of phage types
The distribution of studied S. aureus isolates in the different
phage groups are shown in Tables 4 and 5 and Figs. 5 and
6. A 76.4% of the total isolates were typable by IPS (83.1%
in MSSA and 64.2% in MRSA strains) and 30.7% (16.8%
in MSSA – 35.7% in MRSA) were non typable. There were
55 different phage typing patterns among 64 MSSA isolates,
while 21 various patterns of 27 typable MRSA isolates. The
predominant phage group in the study belonged to the Mixed
group (64.8%) followed by group III (see Fig. 7).Some isolates showed identical phage pattern. In MSSA,
the most common identical phage typing patterns were seven
in 15 isolates as follows:
(79/80/6/42E/47/53/54/75/77/83A/52A/29. n= 2 – No. 60
and 56),
(3C/55/71. n= 2 – No. 87 and 102),
(55/94/96. n= 2 – No. 111 and 119),
(47/94/96. n= 2 – No. 109 and 110),
(81/71. n= 2 – No. 84 and 108),
(79/3A/3C/55/71. n= 2 – No. 34 and 80 from wound), and
























































Figure 6 Phage typing patterns of MRSA isolates.
44 M. Al-Khulaiﬁ Manal et al.These data are exhibited in Table 4 and Fig. 5. The preva-
lence of the same phage typing patterns in MRSA (Table 5 and
Fig. 6). These repetitions were shown for MRSA isolates which
typed only with one phage as follows:
(29. n= 3 – No. 22, 70 and 4), (85. n= 2 – No. 101 and
112), (81. n= 2 – No. 15 and 48) and (75. N= 2 – No.
17 and 40).
It was observed identical phage typing patterns between
MSSA and MRSA isolates: (81. No. 97 in MSSA_No. 15
and 48 in MRSA) and (54/85. No. 78 in MSSA_No. 85 in
MRSA).
3.5. Phage lytic groups and antibiotics
In MSSA isolates, it was observed the PG resistance isolates
were distributed in all phage lytic groups, but group III was
the most common (52.3%). All nontypable isolates exhibited
resistant toPG, in addition another four isolates were multire-
sistant to other antibiotics (No. 39) was resistant to TE, Ba,
(No. 82) was resistant to TE, E, and (No. 6 and 76) were resis-
tant toBa. In MRSA isolates, b-lactams resistant isolates were
distributed in all phage lytic groups, but the most common one
was III (40.4%). Also for the AMC, SXT, TE,CIP and MUP
resistance isolates, it was observed that the group III was the
most common.
In MSSA isolates, both GN resistance isolates exhibited
typability by groups II and M.
TE resistant isolate typed by II and III. One isolate which
resistant to SXT was typed by group III/V alone. Both E
and Ba resistance isolates distributed in all lytic groups, but
group III was the most in E resistant isolates (57.1%) whereas
groups I, II and III had the similar high percentage (60.8%) in
Ba resistance isolates. FD resistance isolates typed by I, II, III
and V. Group I typed all FD resistant isolates. Whereas the
group I (34.4%) and III (37.9%) were the most in FD resis-
tance MRSA isolates. AK resistance MRSA isolates were
typed by group III (36%) and II (32%) as a common lyticgroup. Ba resistant isolates typed by all groups except V lytic
group and C resistant isolates typed by II and M groups. All
nontypable isolates distributed among various antibiotics.
4. Discussion
S. aureus could be one of the most dexterous bacteria in
exchanging useful genetic information with other bacterial spe-
cies, also with phages that have genomic DNA materials. As a
clear example, the GC content of Staphylococcal Chromo-
somal Cassette mec (SCC mec) (which have the mecA gene that
responsible for resistance to methicillin) is non Staphylococcal
origin suggested that it may have been acquired long ago in
evolutionary terms. S. aureus could be infected by both poly-
valent or/and host restricted phages so-called staphages
belonging to families: Myoviridae and Siphoviridae (Francki
et al., 1991). Useful transducer genetic elements or jumping
genes could be transferred horizontally in S. aureus popula-
tion. The originated and colonized bacteria from Hospital
(RAFH) reﬂected the epidemiological phenotypic and geno-
typic determinant markers for S. aureus group in Saudi cohort.
It could help for setting up an evaluated antimicrobial usage
strategy.
Clinical microbiology laboratories testing for antimicrobial
agents susceptibility among S. aureus is important to monitor
for emerging resistance patterns (Fabiana et al., 2004). The
emergence of antibiotic resistance was one of the most serious
phenomena of the last 20 years and several strategies have been
proposed to try to tackle it. The selective pressure resulting
from the extensive use of antibiotics has lead to the acquisition
and spread of antimicrobial resistance determinants (Goni
et al., 2004).
In general, MRSA isolates were more resistant to the anti-
biotics than MSSA that may due to: (1) All MRSA strains
have SCC mec which act as harbor for the different Staphylo-
coccal genes, especially resistant encoded gene. (2) Most
MRSA isolates were from inpatients which may expose to dif-
ferent antibiotics causing emerging the resistance or by gain
the resistance from the hospital strains.
Figure 7 Phage typing of S. aureus isolates in different reactions.
(A) MRSA isolate and (B) MSSA isolate that highly sensitive to
phage types in different reactions (strong reaction–weak reaction).
Phage typing, PCR ampliﬁcation for mecA gene, and antibiotic resistance patterns 45MRSA often displays a resistance to a wide variety of anti-
microbial agents including non-b-lactams, which makes it dif-
ﬁcult to treat of MRSA infections and leads to a high mortality
rate in immuno compromised hosts (Lee et al., 2001).
Phenotypic and genotypic disseminating analysis were per-
formed in this study using antimicrobial agents, international
phage typing (IPT), mecA gene revealed diversity between
the 119 clinical S. aureus epidemiologically unrelated isolates
from one Hospital (RAFH).
4.1. Could phage alter bacterial susceptibility to antibiotics?
In the present study, it was clinically crucial to determine
rapidly, whether S. aureus methicillin resistant or not. Data
revealed that mechanism expressing mecA gene as an impor-
tant one against methicillin in S. aureus, differed among thestudied 119 clinical isolates. A 77 of them were disseminated
as MSSA lacking mecA and 42 were MRSA showed pheno-
typic resistance to methicillin. A 39 of them harbored mecA
gene except three isolates. The characteristic cards of these
isolates are:
 No. 58 – out p., wound, I/II/III/M/V, antibiogram (A)
 No. 30 – in p., nose I/III, antibiogram (A)
 No. 31 – in p., swab, nontypable, antibiogram (H)
The structural gene for methicillin resistance, mecA, en-
codes a novel penicillin binding protein (PBP)-20, which has re-
duced afﬁnity for b-lactam antibiotics (Hartman and Tomasz,
1984). SCCmec is found in another staphylococcus species from
which is presumed to have been transferred; however the origi-
nal donor of mecA to Staphylococci is unknown, as the element
has not yet been identiﬁed outside this genus. Staphylococcus
sciuri has an intrinsic PBP that shares 87.8% amino acid
homology with PBP-20 (Wu et al., 1996). It means that mecA
gene mechanism is diverse, and the presented studied S. aureus
group is heterogeneous and homogeneous population.
These strains can arise because of hyper production of
b-lactamase, production of normal PBP with altered binding
capacity, and/or other as yet unidentiﬁed factors (Chambers,
1997). The increase of phage group II had been linked to a fre-
quent use of beta-lactam antibiotics (Renneberg and Rosdahl,
1992).
Phage-typing data on MRSA strains indicated high special
prevalence of phage type II with a increase for phages 3A and
3C. Phage type II on MSSA considered as an epidemiologic
marker with frequent strong reaction typability (79.1%) indi-
vidually or mixed with other phage groups compared to group
III (67.2%) and phage group I (56%). Contrarily, Blouse et al.
(1979) found weak lytic reaction with group II phages. The
increase of phage group II had been linked to a frequent use
of b-lactams.
Many MRSA strains showed heterogeneously resistance to
b-lactams (Al-Shammary, 1997; Salyers and Whitt, 1994).
Blair and Carr (1961) successfully induced and isolated tem-
perate phages from drug-resistance and proved the roll of
the integrated prophage. Recently, from Saudi, Al-Digs
(2004) studied another episode of S. aureus population from
the same hospital (RAFH), induced and classiﬁed 8 new very
virulent and two temperate staphages from highly incidence
prophages (3–4) inside the individual S. aureus. Phage group
III resembled the highest typability for S. aureus followed by
group I that started to appear. Remarkably, phage group II
did not exist mostly in that previous study.
The investigators suggested that the conﬂict ﬁndings could
be due to a variable and complex expression of resistance
among the different MRSA sub-populations or strains (de
Lencastre et al., 1991). Besides, some MRSA isolates may have
incomplete regulator genes (mecI and/or mecR1) and/or high
genomic diversity as was recently reported.
Numbers of antibiograms for MSSA isolates were less than
MRSA as revealed in Figs. 2 and 3. It was observed in MSSA
that resisted only one antibiotic as different antibiograms (a, m
and n) and was the most resistant antibiogram that resembled
PEN (46.7%). MSSA antibiograms started to show sporadic
of antimicrobial resistance for some isolates. The emergence
of individual antibiotic/antibiogram resistance in MSSA
isolates such as B, FD were observed in Fig. 2 as a serious
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within MSSA population exhibited horizontally distributed
resistance only to one antibiotic and continued building up this
resistance to be more than one vertically in MRSA population
for the same of them such as mentioned for FD, B and E in
Fig. 3. Crisostomo et al. (2001) found that two of the early
MSSA strains exhibiting resistance only to PG, were geneti-
cally similar to the properties of two internationally spread
MRSA. Also, showed resistance only to b-lactams and another
contemporary multi resistant MRSA widely spread. The pat-
tern of multi drug resistance that characterizes the nosocomial
strains may be result of the exposure to multiple antibiotics.
Theses increased susceptibility patterns among CMRSA
strains was consistent with other investigations (Herold
et al., 1998).
Alternative drugs should be used when resistance is high
(French, 2001), this was clear for the increasing resistance of
MSSA to a topical Ba (29.8%) rather than MRSA (19%). In
this study, the resistance rate for MSSA had increase to 9%
for FD antibiotic comparing with the other studies (Turnidge
and Collignon, 1999). In the Australian study found rates of
1–3%. Similar low rates similar that in Canada (0.6%) in
1995 (Tomazs and Barriault, 1995). Also in MRSA isolates,
this rate was highly in present study 69%, while it was reported
a decrease to 31% in previous study (Al-Digs, 2004). The rea-
sons of this selection were due to the widely use FD in unrea-
sonable quantities that led to the emergence of resistance
rapidly. Manson and Howard (2004) found signiﬁcant rela-
tionship between the use of topical FD and the isolation of
MSSA resistant organism at the individual patient level and
support the hypothesis that the observed increase in resistance
is causally associated with the increased use of topical FD.
The emergence and global spread of MRSA may be viewed
as a process of accelerated evolution (Tomasz, 1998), which
took place in the contemporary clinical environment (Crisosto-
mo et al., 2001).
Type 95, a phage type has been shown to be strong and sta-
bile colonizer (Vintov et al., 2003). This type 95 had emerged
and another phage group II had noticed to be important in
the present study. In addition, the importance of this type 95
was obviously noticed with a percentage of (18%) for MSSA
had lowest existence comparing to the other phages. The
change in phage type pattern showed that the increase was
caused by the introduction and spread of many resistant
strains of type 95 and group V, and an increased occurrence
e of resistant strains of phage group II. These could suggest
the undergoing similar changes in the distribution of types,
probably also inﬂuenced by selective pressures through the
use of PG and other drugs (Vintov et al., 2003). The usage
of TE for MSSA promoted the resistance strains 82 and 78
(PG, TE and E) for antibiogram g in Fig. 2. As well as another
isolate in antibiogram i and k showed resistant for (PG, TE)
and (PG, TE, B). These four isolates had different in phage
types. Three of them showed that phage type 80 (group I)
was eradicated as a marker phage for frequency resistance of
PG, except isolate 78 that typed by it. The promotion also ex-
tended to have another type of phage 83A (group III) that was
mentioned by Vintov et al. (2003), who proved a link of the
new mentioned antibiogram and the emerged phage due to
the multiple resistant. Among MSSA isolates, increased vari-
ability to antimicrobial agents. However, the persistence of
one predominant clone of MSSA was shown several differentstrains of both MSSA and MRSA were capable of maintaining
persistent colonization (Trzcinski et al., 1997). A Japanese
study, conducted in 1999 and 2000, of 229 S. aureus isolates
from a variety of skin infections in outpatients reported a
21% prevalence of MRSA (Nishijima and Kurokawa, 2002).
When GN was used, physicians should be alert to the possibil-
ity of the emergence and potential spread of resistance (Lewis
and Altemeier, 1978). In the present study two isolates of
MSSA (No. 84 and 108) started to emerge a resistant to GN
and PG. Also correlated to phage type 81/71 (II/M).
Sunderrajan and Kale (1984) concluded the correlation
with the penicillinase production and the isolates phage
groups. He noticed that multidrug-resistance and penicillinase
production was higher in isolates from operation theatres.
Crossley and Archer (1997), stated that the particularly viru-
lent, penicillinase-producing strain of phage type 80/81, in
which the isolates were sensitive only to phages 80 and 81, be-
came persistently prevalent in multiple countries during
the1950s. After several years, outbreaks of penicillinase-pro-
ducing isolates with phage type 52/52A/80/81 also appeared.
It was determined lately; the prototype 80/81 strain carried a
cryptic defective prophage (designated 800) that conferred
resistance to phages 52 and 52A. All of the isolates that were
sensitive to group I, II, or group V phages were sensitive to
methicillin. Of the isolates that were sensitive to group III
phages, 96% were methicillin resistant, and 70.5% of them
were sensitive to phage 75 and 85 (Samra et al., 2001). Chang-
ing in phage type pattern showed that the increase was caused
by the introduction and spread of many resistant strains of
type 95 and the 94, 96-complex (Vintov et al., 2003). During
the last decade, resistance to GN showed high performance
through MRSA isolates 90% for MRSA and 5.7% for MSSA
(Al-Shammary, 1997) compared to ours which was 69% for
MRSA while it was 2.5% for MSSA.
The distribution of various phage types could be considered
as an indicator for the outbreak of infection associated with a
predominant phage type, this could demonstrate the spread of
MRSA in Saudi hospitals. In our situation, if phage type
80/81/75 was prevalence in the population and introduced by
phage group M or/V such as phage type 95 as mixed such as
group or individually, that could be phage type indicator for
an emergence resistance threatening.
Phage type 95 and 29 were remarkably increased in the
MRSA population compared to MSSA.
Depending on a phage marker (85 or 54) which was pre-
dominant in isolates. It was clear to discriminative isolates into
a major group was typed by this phage indicator. That had
42.8% prevalence of this marker.
In 64 typed MSSA isolates, was observed to lack the simi-
larity of phage typing patterns within about 55. It means dif-
ferent distribution of number and type of phage for each
isolate which was unrelated.
Typically, the response to particular phage was consistent
for isolates representing the same strain, and thus a panel of
diverse phages could be used to identify and differentiate of
S. aureus. MRSA isolates reﬂected somehow of homogeneity
concerning phage typing. The nontypable isolates were
15.1% in S. aureus may reﬂect a variety of circumstances,
including the absence of an appropriate cell surface receptor
for the phage restriction–modiﬁcation systems that prevent
replication of phage DNA, or the presence of an incompatible
lysogenic phage. The phage type assigned to an isolate indi-
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sensitive, typable) (Crossley and Archer, 1997).
It could be concluded from the study, that we do have an
accumulating multiresistant isolates especially for FD, B, E,
and TE. This mainly originated from wound and nose and
the phage could integrate especially groups I and II in increas-
ing the virulent factors in MRSA. As well as studying the ge-
netic back ground of MSSA isolates by combining the
phenotypic as well as genotypic may reﬂect the behavior of
S. aureus for acquiring the source of resistance from its origin.
In addition of using each individual special isolates for the
evaluation of antibiotic susceptibility.
In recent years, there has been an alarming increase in nos-
ocomial Staphylococcal infections by strains with multiple
drug resistance. At present, this situation is leading to evalua-
tion of Staphylococcal pathogens potentially resistant to any
available antibiotic.
5. Conclusion
It is important for Clinical microbiology laboratories that test-
ing for antibiotics among S. aureus to monitor for emerging
resistance patterns (EMSSA).
Phenotypic and genotypic analysis performed in this study
revealed diversity in the epidemiologically between MSSA/
MRSA studied isolates.
Heterogeneity inside MSSA for having virulent factors was
so wide, while it is homogenized for MRSA, i.e. the variations
between MSSA isolates seemed to be horizontally, while in
MRSA were vertically.
The emergence of virulence strains was contributed by exis-
tence strains that had resistance to FD.
Alternative drugs should be used when resistance is high,
this was clear for the increasing resistance of MSSA to Ba.
The resistance rate for FD due to the widely use of FD in
unreasonable quantities that led to the emergence of resistance
rapidly.
Three MSSA isolates showed fully sensitive seemed to be
native wild type.
All MRSA showed fully resistant to b-lactams.
Phage type Ø95 is a new phage type, strong and stabile
colonizer.
The changes in phage typing pattern showed that the in-
crease was caused by the introduction and spread of many
resistant strains.
The phage marker Ø85 or/and Ø54 which common in most
isolates.
MRSA isolates reﬂected somehow of homogeneity concern-
ing phage typing rather than MSSA.References
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